| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 6097 |
| 1 | ADALIMUMAB | 4786 |
| 2 | PREDNISONE | 4455 |
| 3 | ALBUTEROL SULFATE | 4197 |
| 4 | TOFACITINIB | 4170 |
| 5 | ACETAMINOPHEN | 4071 |
| 6 | ERGOCALCIFEROL | 3789 |
| 7 | TIRZEPATIDE | 3729 |
| 8 | METHOTREXATE SODIUM | 2950 |
| 9 | ASPIRIN | 2734 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 964 | 0.2797 |
| 1 | ERGOCALCIFEROL | 3789 | 0.1274 |
| 2 | HUMAN IMMUNOGLOBULIN G | 1664 | 0.0795 |
| 3 | BREMELANOTIDE | 88 | 0.0765 |
| 4 | PSYLLIUM HUSK | 84 | 0.0622 |
| 5 | PEXIDARTINIB HYDROCHLORIDE | 43 | 0.0600 |
| 6 | ORFORGLIPRON | 147 | 0.0481 |
| 7 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 193 | 0.0424 |
| 8 | CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES | 375 | 0.0410 |
| 9 | NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE | 332 | 0.0390 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 8336 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 7606 |
| 2 | GLP-1 Receptor Agonist [EPC] | 7171 |
| 3 | Interleukin-4 Receptor alpha Antagonist [EPC] | 6097 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 6085 |
| 5 | Kinase Inhibitor [EPC] | 4126 |
| 6 | Provitamin D2 Compound [EPC] | 3789 |
| 7 | Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] | 3729 |
| 8 | Benzodiazepine [EPC] | 3610 |
| 9 | Proton Pump Inhibitor [EPC] | 3345 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1051 | 1.5276 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 374 | 0.1802 |
| 2 | Adrenocorticotropic Hormone [EPC] | 125 | 0.1397 |
| 3 | Provitamin D2 Compound [EPC] | 3789 | 0.1273 |
| 4 | Human Immunoglobulin G [EPC] | 1887 | 0.0896 |
| 5 | Interleukin-17A Antagonist [EPC] | 3068 | 0.0823 |
| 6 | Melanocortin 4 Receptor Agonist [EPC] | 17 | 0.0596 |
| 7 | Cortisol Synthesis Inhibitor [EPC] | 35 | 0.0463 |
| 8 | Medium-chain Triglyceride [EPC] | 25 | 0.0451 |
| 9 | Plasma Kallikrein Inhibitor [EPC] | 107 | 0.0446 |